Internal ribosome entry site rna: a new target for blocking hepatitis c virus protein synthesis and replication

Projektinformationen

JOSE GALLEGO

ID Finanzhilfevereinbarung: QLK2-CT-1999-51436

Projekt abgeschlossen

Startdatum 1 August 2000

Enddatum 31 Juli 2002

Finanziert unter

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Gesamtkosten € 114 272,00

EU-Beitrag € 114 272,00

Koordiniert durch

MRC Laboratory of Molecular Biology
United Kingdom

Ziel

The solution structure of domain III in the internal ribosome entry site of HCV RNA will be determined using multi-dimensional NMR spectroscopy. This research will provide new molecular targets for the design of anti-HCV drugs.

Wissenschaftliches Gebiet

• natural sciences › biological sciences › microbiology › virology
• medical and health sciences › health sciences › infectious diseases › RNA viruses › hepatitis C
• natural sciences › biological sciences › biochemistry › biomolecules › proteins
• natural sciences › physical sciences › optics › spectroscopy › absorption spectroscopy
• natural sciences › biological sciences › genetics › RNA

Programm/Programme

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Thema/Themen

• 1.1.1.-2. - Key action Control of Infectious Diseases

Aufforderung zur Vorschlagseinreichung

Data not available

Finanzierungsplan

RGI - Research grants (individual fellowships)

Koordinator

MRC Laboratory of Molecular Biology

• EU-Beitrag: Keine Daten
• Adresse: Hills Road ; CB2 2QH Cambridge ; Vereinigtes Königreich
• Gesamtkosten: Keine Daten